Literature DB >> 31385720

Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers.

A Doran Bostwick1,1, Barbara E Jones1,1, Robert Paine1, Matthew Bidwell Goetz2, Matthew Samore3,4, Makoto Jones3,4.   

Abstract

Rationale: The 2016 guidelines for hospital-acquired pneumonia (HAP) suggest applying a universal antibiogram resistance threshold in addition to patient criteria to determine empiric coverage. The impact of these recommendations is unknown.
Objectives: 1) Describe national antibiotic use and microbiology patterns for HAP among patients with noninfectious admissions, 2) measure the predictive performance of the antibiogram threshold and risk factors, and 3) estimate the change in practice with guideline implementation.
Methods: We conducted a retrospective analysis of all hospitalizations without initial infection but with secondary pneumonia diagnoses at Veterans Affairs Medical Centers between October 1, 2012, and September 30, 2015. For each hospitalization we extracted: presence of methicillin-resistant Staphylococcus aureus (MRSA) and resistant gram-negative rods (R-GNR) in cultures, anti-MRSA and antipseudomonal antimicrobial administration, and facility-level prevalence of MRSA and R-GNR. We calculated the percentage of hospitalizations with resistant organisms, broad-spectrum antibiotics, and the predictive performance of patient characteristics and prevalence thresholds for MRSA.
Results: Among 3,562 cases, 5.17% were positive for MRSA and 2.30% for R-GNR. The recommended MRSA prevalence threshold was 100.00% sensitive (95% confidence interval [CI], 98.02-100.00%) and 0.03% specific (95% CI, 0.00-0.16%) for MRSA-positive culture, leading to overtreatment of 94.81% (95% CI, 94.02-95.50%) of patients. Pressor order (odds ratio [OR], 3.89; 95% CI, 1.17-12.91) and intravenous antibiotics within the past 90 days (OR, 1.98; 95% CI, 1.03-3.81) were associated with MRSA. Mechanical ventilation was associated with R-GNR (OR, 4.37; 95% CI, 1.52-12.57).Conclusions: The guideline-recommended antibiogram threshold and characteristics did not improve prediction of MRSA or R-GNR and would have led to an increase in MRSA treatment.

Entities:  

Keywords:  antibiograms; hospital-acquired pneumonia; resistance

Mesh:

Substances:

Year:  2019        PMID: 31385720      PMCID: PMC6945471          DOI: 10.1513/AnnalsATS.201902-162OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  21 in total

1.  Multicenter study of hospital-acquired pneumonia in non-ICU patients.

Authors:  Nieves Sopena; Miquel Sabrià
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

3.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

4.  Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.

Authors:  Pervin Korkmaz Ekren; Otavio T Ranzani; Adrian Ceccato; Gianluigi Li Bassi; Eva Muñoz Conejero; Miquel Ferrer; Michael S Niederman; Antoni Torres
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

5.  High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia.

Authors:  Doo Ryeon Chung; Jae-Hoon Song; So Hyun Kim; Visanu Thamlikitkul; Shao-Guang Huang; Hui Wang; Thomas Man-Kit So; Rohani M D Yasin; Po-Ren Hsueh; Celia C Carlos; Li Yang Hsu; Latre Buntaran; M K Lalitha; Min Ja Kim; Jun Yong Choi; Sang Il Kim; Kwan Soo Ko; Cheol-In Kang; Kyong Ran Peck
Journal:  Am J Respir Crit Care Med       Date:  2011-09-15       Impact factor: 21.405

6.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.

Authors:  Marin H Kollef; Andrew Shorr; Ying P Tabak; Vikas Gupta; Larry Z Liu; R S Johannes
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

Review 7.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.

Authors:  James D Chalmers; Catriona Rother; Waleed Salih; Santiago Ewig
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

8.  National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module.

Authors:  Margaret A Dudeck; Lindsey M Weiner; Katherine Allen-Bridson; Paul J Malpiedi; Kelly D Peterson; Daniel A Pollock; Dawn M Sievert; Jonathan R Edwards
Journal:  Am J Infect Control       Date:  2013-12       Impact factor: 2.918

9.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

10.  Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study.

Authors:  Jordi Vallés; Ignacio Martin-Loeches; Antoni Torres; Emili Diaz; Iratxe Seijas; Maria José López; Pau Garro; Carlos Castillo; Jose Garnacho-Montero; María del Mar Martin; Maria Victoria de la Torre; Pedro Olaechea; Catia Cilloniz; Jordi Almirall; Fernando García; Roberto Jiménez; Estrella Seoane; Cruz Soriano; Eduard Mesalles; Pilar Posada
Journal:  Intensive Care Med       Date:  2014-03-18       Impact factor: 17.440

View more
  3 in total

Review 1.  Pneumonia in Nervous System Injuries: An Analytic Review of Literature and Recommendations.

Authors:  Zohreh Erfani; Hesan Jelodari Mamaghani; Jeremy Aaron Rawling; Alireza Eajazi; Douglas Deever; Seyyedmohammadsadeq Mirmoeeni; Amirhossein Azari Jafari; Ali Seifi
Journal:  Cureus       Date:  2022-06-02

2.  A Pragmatic Machine Learning Model To Predict Carbapenem Resistance.

Authors:  Ryan J McGuire; Sean C Yu; Philip R O Payne; Albert M Lai; M Cristina Vazquez-Guillamet; Marin H Kollef; Andrew P Michelson
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

Review 3.  Ventilator-associated pneumonia in adults: a narrative review.

Authors:  Laurent Papazian; Michael Klompas; Charles-Edouard Luyt
Journal:  Intensive Care Med       Date:  2020-03-10       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.